Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
5.24
-0.12 (-2.24%)
At close: Feb 13, 2026, 4:00 PM EST
5.34
+0.10 (1.91%)
After-hours: Feb 13, 2026, 5:13 PM EST
Bicycle Therapeutics Market Cap
Bicycle Therapeutics has a market cap or net worth of $363.49 million as of February 13, 2026. Its market cap has decreased by -58.78% in one year.
Market Cap
363.49M
Enterprise Value
-279.09M
1-Year Change
-58.78%
Ranking
Category
Stock Price
$5.24
Market Cap Chart
Since May 23, 2019, Bicycle Therapeutics's market cap has increased from $212.36M to $363.49M, an increase of 71.17%. That is a compound annual growth rate of 8.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 363.49M | -25.99% |
| Dec 31, 2025 | 491.12M | -49.19% |
| Dec 31, 2024 | 966.64M | 26.03% |
| Dec 29, 2023 | 766.98M | -12.72% |
| Dec 30, 2022 | 878.81M | -50.89% |
| Dec 31, 2021 | 1.79B | 367.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immutep | 409.10M |
| Benitec Biopharma | 399.07M |
| Monopar Therapeutics | 396.88M |
| Entrada Therapeutics | 396.63M |
| PepGen | 393.93M |
| Absci | 390.97M |
| NovaBridge Biosciences | 390.84M |
| Greenwich LifeSciences | 384.19M |